Statin Use, Lipids, and 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase Inhibition on Risk of Idiopathic Pulmonary Fibrosis.

Zhao, Sizheng Steven; Alton, Philip; Rogers, Kira; Hughes, David M

Zhao, Sizheng Steven; Alton, Philip; Rogers, Kira; Hughes, David M.

Afiliación

Zhao SS; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom. Electronic address: Sizheng
Alton P; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom.
Rogers K; Manchester Medical School, The University of Manchester, Manchester, United Kingdom.
Hughes DM; Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom.

Clin Ther ; 46(1): 79-81, 2024 01.

Article en En | MEDLINE | ID: mdl-37978012

Asunto(s)

Inhibidores de Hidroximetilglutaril-CoA Reductasas; Fibrosis Pulmonar Idiopática; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos; Fibrosis Pulmonar Idiopática/tratamiento farmacológico; Coenzima A; Oxidorreductasas; Lípidos

Palabras clave

HMG-CoA reductase; LDL cholesterol; Mendelian randomization; idiopathic pulmonary fibrosis; statins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Fibrosis Pulmonar Idiopática Límite: Humans Idioma: En Revista: Clin Ther Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google